Clinical trials
Pulmonary Disease clinical trials
Below are recruiting pulmonary disease clinical trials, each written for real people, not researchers. We’re tracking 538 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07125352Recruiting
NLR blood test for COPD flare-ups
This study looks at whether the neutrophil-to-lymphocyte ratio (NLR) in your blood can help doctors understand how serious a COPD flare-up is. You may join if you are 18 or older and admitted to the hospital with a COPD exacerbation.
Cairo, AbbasyeaAges 18 years+ - NCT05153967Recruiting
Study late effects after sickle cell curative treatments
This study looks at long-term health effects after curative treatments for sickle cell disease, such as bone marrow transplant. Your participation helps researchers understand what changes over time after treatment, and what might need monitoring or care.
Washington D.C., District of ColumbiaAges 4–65 - NCT06653413Recruiting
Using dynamic chest x-ray to diagnose COPD
This study tests if a new type of chest x-ray (dynamic chest x-ray) can help diagnose COPD. You would breathe normally and deeply while the x-ray takes images for 20 seconds. This could be a more comfortable way to check for COPD compared to standard breathing tests.
Guangzhou, GuangdongAges 40–80 - NCT02966665RecruitingPhase 1
Testing blood vessel function in people of different health conditions
This early study measures how well your blood vessels work using tests that may include MRI. It compares healthy people with people who have conditions like COPD, pulmonary arterial hypertension, heart failure, or high blood pressure, to better understand “vascular function” in health and disease.
Salt Lake City, UtahAges 18 years+ - NCT03450603Recruiting
Predicting COPD flare-up risk in adults
This study looks at factors that can predict when chronic obstructive pulmonary disease (COPD) will flare up. It may help doctors identify people at higher risk sooner and tailor care to prevent flare-ups.
ShanghaiAges 40 years+ - NCT07082738RecruitingPhase 2
Study of AZD6793 for people with moderate to very severe COPD
This trial tests a new drug called AZD6793 for people with moderate to very severe COPD. It aims to see if the drug can help improve breathing and reduce flare-ups.
Birmingham, AlabamaAges 40 years+ - NCT05896800Recruiting
Inhaled nitric oxide for moderate to severe COPD symptoms
This study tests whether inhaled nitric oxide gas can improve outcomes in people with moderate-to-severe chronic obstructive pulmonary disease (COPD). It may help reduce breathing problems by targeting how airways and blood vessels respond in the lungs.
Nanjing, JiangsuAges 40–75 - NCT06366113Recruiting
Morning vs. afternoon exercise for COPD rehab
This study tests whether the time of day you exercise (morning vs. afternoon) affects how much you improve during a COPD rehabilitation program. It may help you get the most benefit from your rehab sessions.
LilleAges 18–85 - NCT06480435Recruiting
Chest physiotherapy and lung squeezing for men with COPD
This study explores whether a chest physiotherapy technique (called lung squeezing) can help men with moderate-to-severe COPD breathe more easily. Participants will receive the therapy and be monitored for improvements.
Lahore, Punjab ProvinceAges 40–60 - NCT06480422Recruiting
Breathing exercises for moderate COPD
This study tests two breathing exercises—autogenic drainage and segmental breathing—to see if they help people with moderate COPD breathe easier. It may help you clear mucus and improve your lung function.
Lahore, Punjab ProvinceAges 40–60 - NCT06488495Recruiting
Exercise program for nontuberculous mycobacterium lung disease
This trial tests whether a structured exercise program can improve symptoms and quality of life in people with nontuberculous mycobacterial (NTM) lung disease. If you have a confirmed NTM lung infection and are having respiratory symptoms, this study may help you build strength and better manage your condition.
SeoulAges 40–80 - NCT06579872Recruiting
Heart-Lung Function and Foot Pressure in COPD
This study looks at how your heart and lungs work together (cardiopulmonary function) and how you put pressure on your feet while walking (plantar pressure) in people with COPD. It may help design better rehabilitation programs.
New Taipei CityAges 45–65 - NCT07474220Recruiting
Study of SLC25A48 in COPD
This study measures a protein called SLC25A48 in people with COPD (a lung condition that makes breathing hard) and in healthy people to learn if it plays a role in the disease.
New Taipei CityAges 18 years+ - NCT06714721Recruiting
Magnetic diaphragm stimulation for COPD
This study tests if magnetic stimulation of the diaphragm muscle can help people with COPD breathe better. If you have had COPD for at least 6 months, are over 18, and can answer questionnaires, you may be eligible.
AnkaraAges 18 years+ - NCT06850961Recruiting
Digital health app for COPD self-management
This study tests a digital health app to help you manage COPD symptoms on your own. It focuses on people who have trouble with mucus and want to use a smartphone for their care.
Bergen, NorwayAges 18–90 - NCT06956742Recruiting
Breathing device study for COPD shortness of breath after exercise
This trial tests a device that briefly opens your airways to help release trapped air after exercise. It may reduce shortness of breath and improve your daily life with COPD.
Rouen, NormandyAges 18 years+ - NCT07053423RecruitingPhase 4
Dupilumab for COPD with airway inflammation
This study tests if a drug called dupilumab, given as a shot under the skin, can reduce airway inflammation in people aged 40-85 with moderate-to-severe COPD who also have signs of a specific type of inflammation called Type 2. It may help if you have frequent flare-ups and are already using multiple inhalers.
Birmingham, AlabamaAges 40–85 - NCT07185659Recruiting
Walking Exercise for COPD Patients
This study looks at whether a walking exercise program can help people with COPD (a lung condition) feel better and breathe easier. It is designed for people who are currently in the hospital and can do gentle walking.
New Taipei City, Xindian Dist.Ages 40–100 - NCT07349524RecruitingPhase 2
A study of an oral tablet for COPD
This study tests an oral tablet called RSS0343 for people with moderate to severe COPD. It aims to see if the tablet can improve lung function and reduce flare-ups when added to your current breathing treatments.
Guangzhou, GuangdongAges 40–80 - NCT07382258Recruiting
Inhaled nitric oxide for COPD: a clinical study
This trial tests whether a gas called nitric oxide, breathed in through the nose or mouth, can help people with moderate to severe COPD. It could improve breathing and quality of life.
Nanjing, JiangsuAges 40–75 - NCT03014609Recruiting
Testing cardiovascular risk in people with COPD
This trial studies cardiovascular (heart and blood vessel) risk in people who have stable COPD or a recent worsening of COPD. It may help researchers understand which risks to monitor during and after a COPD flare and how to prevent complications.
Grenoble, La TroncheAges 18–85 - NCT07418736RecruitingPhase 2
CM326 for moderate to severe COPD
This trial tests a new medicine called CM326 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve lung function.
Beijing, Beijing MunicipalityAges 40–85 - NCT07469111Recruiting
Low-weight arm exercises with blood flow restriction for COPD patients
This trial tests whether doing light arm exercises while wearing a cuff that slightly restricts blood flow can help people with COPD improve their arm strength and function without heavy weights.
Malatya, BattalgaziAges 40–80 - NCT07574879RecruitingPhase 1
H. pylori Treatment Effects on COPD Symptoms
This study tests whether treating a stomach bacteria infection (H. pylori) can improve breathing and lung function in people with COPD. Researchers want to see if eliminating this bacteria helps reduce COPD symptoms.
Zagazig, ElsharkiaAges 40 years+
Hear when a new Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary disease?
- Yes. Clin2 currently lists 538 recruiting pulmonary disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.